MCC Update 12-17-13
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. This is the final issue for the year. The next issue will be published on January 7, 2014. All submissions for the next issue must be sent to Sandi Sherman, firstname.lastname@example.org, by noon on Friday for publication the following Tuesday.
December 17, 2013
PLEASE NOTE: This seminar will be simulcast to 450 MCRB. Shuttles to CCRB may be boarded in front of Variety Club Heart Clinic on E. River Parkway. See website for details on pick-up time.
Tuesday, December 17, 2013, 12-1 p.m., 1-125 CCRB
Noncoding RNAs are novel regulators in ovarian cancer
Lynne T. Bemis, Ph.D., Chair, Biomedical Sciences, Program Director, Native American Faculty Development Program, University of Minnesota Medical School-Duluth
Hosts: Jim McCarthy, Ph.D., and Kalpna Gupta, Ph.D.
A peek at the next seminar:
Tuesday, January 7, 2014, 12-1 p.m., 2-125 CCRB
Fast & dangerous: Microscale in vitro models of dynamic pathologic processes
David K. Wood, Ph.D., Assistant Professor, Department of Biomedical Engineering, University of Minnesota
Visit the calendar for a schedule of seminars.
Members in the news
Research findings showing new genetic links to infant leukemia were reported in the Academic Health Center’s Health Talk blog. The research was conducted by Julie Ross, Ph.D., Prevention and Etiology Program, and colleagues from the U of M and Washington University in St. Louis.
Dorothy Hatsukami, PhD., Masonic Cancer Center associate director of cancer prevention and control, was interviewed on WCCO-TV, KARE-TV, KTTC-TV, the Star Tribune, and BringMeTheNews about a U of M study looking at the potential dangers of e-cigarettes. The research study was also mentioned in Duluth News Tribune Health Note. Hatsukami was also quoted in Healthline and Yahoo! Health stories about research linking e-cigarettes to heart attack risk.</p>
Celalettin Ustun, M.D., Transplant Biology and Therapy Program, was quoted is the Academic Health Center Health Talk blog story about a U of M study testing the effectiveness of reduced intensity condition allogeneic hemaotpoietic transplantation in patients with acute myeloid leukemia.
Jeffrey Miller, M.D., Transplant Biology and Therapy and Immunology programs, was quoted in The Oncology Report about studies showing that the age barrier for half-matched bone marrow transplantations has fallen for patients with hematologic malignancies.
The following clinical trials conducted by Masonic Cancer Center members were recently opened:
A Phase 2, Randomized Study to Assess the Safety and Anti-Cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections that are Resistant or Refractory to Treatment with Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
PI: Green, Jaime
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Refractory
Neuroblastoma and Pheochromocytoma - A Best Available Therapy/Compassionate Use Protocol
PI: Greengard, Emily
For more information on clinical trials contact Marva Bohen, R.N., B.S.N. (email@example.com, 612-624-2620).
December 17, 2013: Department of Medicinal Chemistry special seminar
3:30 p.m., Room 105, 717 Delaware building
Chemical Probes for Cancer & Neuroscience
Jeffrey Aubé, Professor , Department of Medicinal Chemistry, University of Kansas
December 18, 2013: Cancer Biology Journal Club
12-1 p.m., 6-101 NHH
Jenna Benson, Ph.D., Kelekar lab, will discuss “p53 status determines the role of autophagy in
pancreatic tumour development,” Rosenfeldt MT et al., Nature 2013;504:296-300.
December 19, 2103: Stem Cell Institute research conference series
4 p.m., 1-110 McGuire Translational Research Facility
Curiosity, Craziness & Courage: How They Lead Us to Cancer’s Achilles Heel
Anindya Bagchi, Assistant Professor, Department of Genetics, Cell Biology & Development, University of Minnesota
January 22, 2014: Writing Winning Grants
8:30 a.m.-4 p.m., McNamara Alumni Center
Want to write successful health research grants? Then don't miss "Write Winning Grant Proposals," a day-long seminar that will comprehensively address practical and conceptual aspects important to the proposal-writing process.
Registration fee: $75
The seminar is hosted by the Clinical and Translational Science Institute, Center for Health Equity and Minnesota Center for Cancer Collaborations. Register for the event.
Visit the Education and Training Opportunities web page for more conference and special lecture listings.
May 17, 2014: Save the Date: Cancer Survivorship Series
Click here to be added to the Cancer Survivor Program mailing list to receive registration information for this conference when it is available closer to the date.
Visit the Community Events and Outreach page for more information.
News & Notices:
Grant-in-Aid Information Session
The spring deadline for the Grant-In-Aid is February 10. Please join us on Tuesday, January 14, from 1:00 to 2:30 pm in Room 101 Walter Library for a discussion of the requirements and review process of the Grant-in-Aid program for general (i.e. non-medical) proposals.
CTSI Clinical Data Office Hours Now Open
Interested in getting patient data for your research? CTSI is now hosting Clinical Data Office Hours twice a week, on Tuesdays from 2:30-3:30pm at 717 Delaware St. SE, Room 212 and Thursdays from 10-11:30am in Diehl Hall, Room 350G. Visitors can learn more about the clinical data repository, which houses electronic medical records of more than 2 million patients, discuss their request for clinical data, see a demo on using the Data Shelter, and get help using the i2b2 cohort-discovery tool. Learn more, and reserve your spot.
CTSI Announces Grant Program for Conducting Health Research at the State Fair
The new Driven to Discover Community Health Research Grants Program will support pilot research and evaluation projects that address important Minnesota human health issues and enable Minnesota State Fair attendees to participate. The grant program from the Clinical and Translational Science Institute (CTSI) will award 2-6 grants worth a combined $30,000 to support researchers' efforts to enroll and collect data from 2014 State Fair attendees in the U of M's new Driven to Discover research building. Learn more, download the RFP, and apply by the Jan. 31 deadline.
St. Baldrick's 2014 Spring Funding Opportunities
St. Baldrick’s Foundation
Deadline for Internal Review: January 8, 2014
Full application deadline: April 4, 2014
Funding: $5,000 - $330,000 depending on opportunity
UMN is allowed to submit one application per grant opportunity, and two for the Research Grants. Grants include:
- St. Baldrick's Fellows
- St. Baldrick's Scholars
- St. Baldrick's International Scholars
- Research Grants
- Supportive Care Research Grants
- Consortium Research Grants
- St. Baldrick's Summer Fellows
The Damon Runyon Clinical Investigator Award
Damon Runyon Cancer Research Foundation
Application Receipt Date: February 18, 2014
Funding: $450,000 over three years
NOTICE: Institutional nominations are no longer required.
U.S-South Africa Program for Collaborative Biomedical Research
National Cancer Institute
Application Receipt Date(s): April 22, 2014
Funding: Standard NIH limits apply.
Administrative Supplements for Research on Sex/Gender Differences (Admin Supp)
National Cancer Institute
Application Receipt Date(s): February 06, 2014
Funding: $100,000 total costs
Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50)
National Cancer Institute
Application Receipt Date(s): February 13, 2014; May 20, 2014; September 23, 2014
Funding: $2,300,000 total costs/year for each of 5 years
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21)
National Cancer Institute
Application Receipt Date(s): February 19, 2014; February 19, 2015
Funding: up to $125,000 direct costs per year for 2 years
Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.